| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Obatoclax Mesylate | CTRPv2 | pan-cancer | AAC | 0.0071 | 0.8 |
| mRNA | ML258 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |
| mRNA | Carboplatin | CTRPv2 | pan-cancer | AAC | -0.007 | 0.9 |
| mRNA | pac-1 | CTRPv2 | pan-cancer | AAC | -0.0066 | 0.9 |
| mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0057 | 0.9 |
| mRNA | WZ4002 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | ifosfamide | CTRPv2 | pan-cancer | AAC | 0.0086 | 0.9 |
| mRNA | A-804598 | CTRPv2 | pan-cancer | AAC | -0.0074 | 0.9 |
| mRNA | BRD-K03911514 | CTRPv2 | pan-cancer | AAC | 0.0082 | 0.9 |
| mRNA | BRD-M00053801 | CTRPv2 | pan-cancer | AAC | 0.0075 | 0.9 |